Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 Aug 18;18(8):e0290115. doi: 10.1371/journal.pone.0290115

Strengthening systems to provide long-acting reversible contraceptives (LARCs) in public sector health facilities in Uganda and Zambia: Program results and learnings

Aniset Kamanga 1,#, Micheal Lyazi 2,#, Margaret L Prust 3, Naomi Medina-Jaudes 3, Lupenshyo Ngosa 1, Margaret Nalwabwe 2, Martha Ndhlovu 1, Dynes Kaluba 4, Angel Mwiche 4, Richard Mugahi 5, Joy Batusa 2, Morrison Zulu 1, Andrew Musoke 2, Hilda Shakwele 1, Caitlin Glover 3, Emma Aldrich 3,*
Editor: Lea Sacca6
PMCID: PMC10437908  PMID: 37594954

Abstract

Introduction

In Uganda and Zambia, both supply- and demand-side factors hamper availability of long-acting reversible contraceptives (LARCs), including implants and intrauterine devices (IUDs), at public sector facilities. This paper discusses results of a program aimed at increasing access to and uptake of LARC services in public sector facilities through capacity building of government health workers, strengthening government supply chains, and client mobilization.

Methods

From 2018–2021, the Ministries of Health (MOHs) in Uganda and Zambia and Clinton Health Access Initiative (CHAI) worked to increase readiness to provide LARC services within 51 focal facilities in Uganda and 85 focal facilities in Zambia. Annual facility assessments of LARC-related resources were conducted and routine service delivery data were monitored.

Results

At baseline, few focal facilities had supplies and skilled staff to provide LARC services. At endline, over 90% of focal facilities in both countries had a provider trained to provide both implants and IUDs and 55% had the commodities and equipment needed for implant provision. In Uganda and Zambia, respectively, 65% and 38% of focal facilities had commodities and equipment for IUD provision at endline. Both programs observed significant increases in the number of implants provided at focal facilities; in Uganda implant volumes increased five-fold from 4,560 at baseline to 23,463 at endline, and in Zambia implant volumes increased nearly four-fold from 1,884 at baseline to 7,394 at endline. Uganda did not observe growth in IUD volumes, whereas Zambia observed significantly increased IUD service volumes from 251 at baseline to 3,866 at endline.

Conclusions

Public sector facilities can be rapidly and sustainably capacitated to provide LARCs when both catalytic and systems strengthening interventions are deployed for health worker capacity building, supply chain management, and community mobilization to ensure client flow. Investments should be intentionally sequenced and coordinated to generate a virtuous cycle that enables continued LARC service provision.

Introduction

In Uganda and Zambia, high numbers of unintended pregnancies contribute to high rates of morbidity and mortality due to unsafe abortion and lack of access to routine and emergency obstetric care. The governments of Uganda and Zambia are committed to increasing access to and use of modern family planning (FP) to reduce unintended pregnancies and maternal morbidity and mortality. For example, the Zambian National Health Strategic Plan of 2022–2026 commits to increase the proportion of women of reproductive age (aged 15–49 years) who have their need for family planning satisfied with modern methods from 68.5% in 2018 to 80% 2026 [1], and in Uganda, the government seeks to increase the modern contraceptive (mCPR), for all women, from 30.4% in 2020 to 39.6% by 2025 and reduce the unmet need for modern contraception from 17% in 2020 to 15% by 2025 [2]. Unintended pregnancies are pregnancies that are mistimed, unplanned or unwanted at the time on conception. Efforts have been made to scale access to long-acting reversible contraceptive (LARC) methods, including implants and intrauterine devices (IUDs), because they are more effective [3] and have higher continuation rates compared to short-acting methods, which require end-users to frequently re-supply and are subject to user error [4]. In addition, LARC methods are more cost-effective on a cost per couple years of protection (CYP) basis, an important consideration as countries move to increase domestic financing for FP product procurement and service delivery [5,6].

Supply- and demand-side factors, however, continue to hamper uptake of LARC services in Uganda and Zambia, especially in the public sector, where most modern contraceptive users receive services [7,8]. Public sector supply-side gaps include insufficient numbers of trained health workers skilled to provide LARC services, persistent gaps in LARC commodities at service delivery points, and lack of essential equipment, medicines and supplies to provide LARCs. At the same time, demand-side issues related to family planning include lack of awareness of LARC benefits and pervasive myths and misconceptions about implants and IUDs [9,10]. As a result, only 17.3% of all contraceptive users in Uganda use implants and 4.1% use IUDs, with overall method share skewed toward short-term contraceptives, such as injectables (51.3%) [11]. Similarly, in Zambia, 17.9% of all contraceptive users use implants and only 1.5% use IUDs, with method share also skewed towards short-term methods, notably injectables (52.8%) [12].

The Zambian and Uganda governments are working to address these issues and expand access to family planning, including LARCs. In Zambia, the government pledged to invest $12 million in family planning programs in 2023, with yearly increases of 30% after that [13]. In Uganda, the government has committed to ring fence 50% of the domestic reproductive health commodities budget for procurement, storage and distribution of FP commodities from by 2025 [14]. Alongside the efforts of the government, international non-governmental organizations (INGOs) have implemented LARC service delivery and demand generation interventions in Uganda and Zambia, circumventing capacity issues in the public sector by deploying donor-funded mobile clinical outreach teams or seconding dedicated family planning providers to the public sector, and by building the capacity of private-sector franchised or affiliated clinics [15]. Neither implementation experiences nor evaluations of the effectiveness of public sector strengthening programs have been widely documented. This paper presents the results of a program that aimed to increase access to and uptake of LARC services within public sector facilities in Uganda and Zambia by building capacity of government-employed health workers while strengthening government systems for service delivery and client mobilization.

Furthermore, the ways in which supply- and demand-related dynamics create a mutually reinforcing cycle, either enabling or inhibiting LARC uptake, have not been well explored in published literature. While low levels of LARC uptake are often attributed to gaps in availability of trained health workers, relevant supplies, or persistent myths and misconceptions, it is often the case that there are relationships between supply and demand factors that contribute to either vicious or virtuous cycles. Fig 1 depicts a virtuous cycle for LARC introduction as developed and used by this program. Anecdotally, it’s been observed that health worker skills may deteriorate post-training when they do not consistently perform the skill immediately following training due to commodity stock outs or insufficient demand and subsequently, client flow. In the absence of frequent opportunities to practice skills and provide the service, health worker competency and confidence to provide the service declines. Because health workers are less likely to provide comprehensive information on methods that they are uncomfortable providing, they’re likely to promote or focus on other contraceptive options, missing opportunities to correct misperceptions and share information on the benefits of LARCs during FP counselling sessions, even if LARC options are more likely to meet clients’ reproductive goals. Having not had their concerns about LARCs addressed, clients go on to select alternative FP options, including popular injectables, and are likely to promote use of injectables or other short-term methods amongst their peer networks. Health workers then interpret the absence of feedback from satisfied LARC users as a signal that clients prefer short-term methods. Given these dynamics, the return on investment on singular, mass trainings which are deployed without consideration for the need to strengthen supply chain and community mobilization systems in tandem is likely to be limited. Programs that employ intentional sequencing of multiple and at times synchronous interventions to disrupt a vicious cycle and establish a new virtuous cycle of supply and demand for LARC uptake have not been widely documented. This paper presents results of a program which addressed immediate gaps preventing service readiness at public sector facilities, while also aiming to establish a virtuous cycle of supply and demand for LARC services, for sustainability and optimal return on investment over time.

Fig 1. Virtuous cycle of LARC availability and provision.

Fig 1

Methods

Program approach

From 2018–2021, the Ministries of Health (MOH) in Uganda and Zambia and Clinton Health Access Initiative, Inc. (CHAI), with funding from The ELMA Foundation and an anonymous donor, worked in partnership to implement an integrated Sexual, Reproductive, Maternal, and Newborn Health (SRMNH) program in selected sub-national geographies in Uganda and Zambia [16]. The program was designed by CHAI and the MOHs, building on previous experience of both countries and with careful consideration and adaptation for the local context and opportunities. CHAI developed a standardized mentorship framework and implementation package to assist focal geographies to address systems and facility-level barriers to SRH access, provision, and uptake. This assisted in addressing the gaps in LARC service provision. CHAI leveraged the pool of family planning government trainers and mentors to build health care worker capacity and drive acknowledgement amongst community traditional leadership of the need to scale up awareness of the benefits of family planning. The main program activities were implemented over a three-year period from 2018 through 2020, whereas the program focused on transitioning technical assistance and ensuring the sustainability of interventions in 2021.

One component of the programs in Uganda and Zambia was to demonstrate how technical assistance partners, local government units and health managers can work together to rapidly improve the availability of LARC methods and services in eligible public sector facilities. The program activities relating to LARCs that were implemented in Uganda and Zambia by CHAI and the government are described in detail in S1 Table. Though the activities were implemented with government collaboration, these activities were beyond and in addition to the routine service support activities performed by the government. These activities were synchronous and rationally paced and aimed to create a virtuous cycle of supply and demand for LARCs while strengthening government systems for sustainable delivery of LARC services and to address systemic barriers to LARC provision and use. Key interventions were implemented in relation to the three foundational input areas described in the virtuous cycle schematic (health worker capacity building, availability of equipment and commodities, and demand generation) as well as in support of strengthening management and information systems to improve availability of routine data to aid decision-making. Interventions were largely implemented by and through existing sub-national government structures and systems, with the aims of ensuring government ownership and sustainable impact over time and facilitating seamless withdrawal of technical assistance at the end of the program. In both Uganda and Zambia, leveraging program interventions, government stakeholders elected to add training, mentorship, peer educator outreach, and supply chain quality improvement activities to annual subnational workplans and, where possible, domestic government budgets to institutionalize LARC service delivery as part of public sector standard operations. Initial training and catalytic supply chain interventions, as well as targeted community mobilization were timed and deployed to increase client flow immediately ahead of health worker trainings and to ensure that LARC-related supplies were available for service delivery post-training. It was particularly important to ensure: LARC products were procured, distributed and available at facilities immediately following training, to ensure health workers could put skills to use immediately, minimizing risk of skills and confidence atrophy; LARC products were not procured too far in advance of training, to avoid running down shelf-life and risk of expiry and wastage; clients were mobilized once training dates were confirmed, to ensure sufficient client flow for training practicum and routine service delivery following training. On-the-job clinical mentoring, supply chain management capacity building, and routine community mobilization activities were then deployed synchronously to support integration of clinical skills into routine service delivery and support facilities to be able to consistently meet increasing demand for services over time, without interruption.

In both countries, the following LARC products were routinely procured through public sector procurement channels during the program period: single-rod etonogestrel implant (Implanon NXT); dual-rod levonorgestrel implant (Jadelle); and non-hormonal (copper) IUD products. Training and mentorship was offered to cadres eligible to provide LARC services in each country, with a focus on nurses, midwives, and clinical officers. Facilities with trained health workers received on-the-job mentoring. Mentorship helped to institutionalize skills within facilities and benefitted multiple health workers beyond those that were trained formally by the program. While mentoring may have helped to cascade skills and mitigate impacts of staff transfers, provider attrition was a reality the program had to contend with. The program coordinated with local leadership to rationalize staff transfers and ensure coverage of trained health workers at program sites. Trained health workers were encouraged to provide on-the-job training to other health workers in their facilities to ensure the availability of services in the event of attrition.

Setting

In Uganda, the program provided support to 51 LARC-eligible government-owned health facilities in six districts, including three hospitals and 48 health centers. These 51 facilities serve an estimated 2,025,000 people in the Kagadi, Kakumiro, Kassanda, Kibaale, Mityana, and Mubende districts. Facilities designated as a health center level three (HCIII) or higher with a midwife are eligible to provide LARC services in Uganda per the 2016 Uganda Clinical Guidelines [17].

In Zambia, the program provided support to 85 LARC-eligible government-owned health facilities in all 12 districts in Northern Province. Together, these facilities serve an estimated 1,520,004 people in Northern Province. All facilities designated as a health center or higher are eligible to provide LARCs in Zambia as per the 2006 Zambia Family Planning Guidelines and Protocols [18].

These areas of Zambia and Uganda were selected by the government as the focal area for this work because they were some of the most underperforming areas of the country on SRMNH-related outcomes, Northern Province, Zambia is a very rural and hard-to-reach areas with no other maternal and newborn health programs active in the province at the time that this program was launched. The selected districts in Uganda are within several hours drive from the capital of Uganda, Kampala, but nonetheless include areas that are hard-to-reach due to poor road networks.

Facility assessments

Facility assessments were conducted in Uganda and Zambia to determine which facilities had the resources and capacity to provide LARCs and other SRMNH services. The facility assessments were conducted by program staff or contractors using tools developed by the program to track the intended program indicators (Table 1) on family planning and other topics. The baseline assessment was conducted in July and August 2018 for Uganda and Zambia, respectively. Beginning in 2019, facility assessments were conducted quarterly through the end of 2020. For both countries, a data collection tool was adapted from the WHO Service Availability and Readiness Assessment (SARA) tool. In Zambia, the draft form for the MOH Service Quality Assessment (SQA) tool also informed the development of the facility assessment data collection tool. The facility assessments were approved by ethical review committees in both countries in July 2018, including the ERES Converge Institutional Review Board (IRB) in Zambia (reference number 2018-Jul-017) the AIDS Support Organization IRB in Uganda (reference number 026/18-UG-REC-009). The IRBs determined that this work did not engage human subjects and that patient consent was not required.

Table 1. Key LARC-related indicators in Uganda and Zambia.

Indicator Definition
Service readiness
Percent of facilities that have at least one trained provider for implants / IUDs Proportion of LARC-eligible program facilities that had at least one provider trained to provide implants / IUDs
Percent of facilities that have at least one mentored provider for implants / IUDs Proportion of LARC-eligible program facilities that had at least one provider mentored to provide implants / IUDs
Percent of facilities that have implant / IUD supply Proportion of LARC-eligible program facilities that had at least one implant / IUD available
Percent of facilities with tracer commodities/equipment for implants Proportion of LARC-eligible program facilities that had tracer commodities/equipment for implants, including: implant, sterile gloves, betadine, cotton balls, lidocaine, and sterile drapes
Percent of facilities with tracer commodities/equipment for IUDs Proportion of LARC-eligible program-facilities that had tracer commodities/equipment for IUDs, including: IUD, sterile gloves, sterile scissors, speculum, tenaculum, and sponge holding forceps
Service provision
Percent of facilities providing implants / IUDs Proportion of LARC-eligible program facilities that provided at least 1 implant / IUD in the last 90 days
Implant / IUD service volumes Number of implants / IUDs provided at LARC-eligible program facilities
Percent of CYPs generated by implants / IUDs Proportion of couple years of protection generated by implants / IUDs at LARC-eligible program facilities

*Slash marks (/) indicate two distinct indicators: One for implants and one for IUDs.

Data were collected in person by CHAI and MOH staff through observations in facilities, administrative record review, and by asking facility leadership questions about service delivery and resource availability. The data collection tools were administered using tablets and SurveyCTO for electronic data collection. Data were collected by phone in 2020, when Uganda and Zambia experienced lockdowns and facility visits were not feasible due to the COVID-19 pandemic.

Routine service delivery data

To track the provision of family planning services at program supported sites, data was extracted from the national health information management system (HMIS), which is hosted on the DHIS2 platform in both countries. CHAI and MOH staff had access to aggregated monthly data. Extreme outliers were observed in rare cases and were followed-up to enable correction of data entry errors. In both countries, INGOs operate mobile clinical outreach teams which are hosted by lower-level public sector health facilities and in some cases, rural communities without a health center, and which provide free family planning services to public sector clients. In both countries, LARC services provided by INGO-employed clinicians via mobile outreach events are recorded in host facility HMIS forms and are reflected in DHIS2 as services provided by that facility.

This data is available in aggregate form without any individualized patient information, and as a result, this work was determined by CHAI’s internal Scientific and Ethical Review Committee to not engage human subjects or require patient consent.

Key indicators

In relation to LARCs, several key indicators were agreed upon at the outset of the program by program and government staff as a foundation to align all stakeholders around strategic goals and measures of success (Table 1). The facility assessment data were used to track service readiness. We define readiness as the presence of the necessary commodities, equipment, and trained staff to provide a specific service. Specifically, for IUDs, the following commodities had to be available and functional on the day of the assessment: IUD, sterile gloves, sterile scissors, speculum, tenaculum, and sponge holding forceps. For implants, facilities were required to have the following commodities available and functional on the day of the assessment: implant, sterile gloves, betadine, cotton balls, lidocaine, and sterile drapes. Facilities were also required to have at least one staff member ever trained in each LARC method to be considered ready to provide the service. In addition, the program tracked the proportion of facilities that had a staff member mentored on each LARC service because mentorship supports integration of skills into clinical practice and helps reinforce skills and confidence over time. Staff were considered trained if they had ever received training in IUD and implant provision, and mentored if they had received at least one targeted, structured mentorship session within the last 12 months. Only staff currently working at the facility and who were not on leave for more than 90 days were counted.

Service provision indicators were monitored from the national HMIS in both countries. Data were available on the number of IUDs and implants reported as provided at each program facility in each month and the total number of IUDs and implants reported as provided over time was also tracked. The program also tracked the percentage of facilities that reported providing at least one implant or IUD per quarter as a measure of which sites were actively providing services. In addition, the program tracked the CYPs generated by LARCs and other modern methods [6]. Specifically, we assessed the percentage of CYPs generated by implants and IUDs out of total CYPs generated by oral contraceptive pills, injectables, implants, and IUDs provided.

Data analysis and program data use

Data in both Uganda and Zambia were monitored using country-specific dashboards that were developed and maintained in GoogleSheets for the duration of the program. The dashboards were linked to the SurveyCTO data collection tools so that a data tab was populated automatically as completed forms were submitted. This enabled monitoring of data as it was being collected and entered into the system, and led to timely correction of the few outliers and errors that were committed during the process. Analysis tabs were created to visualize and summarize the data on which facilities met LARC service readiness requirements and which facilities were providing LARCs. Final additional analyses of data were done using Stata 14. The datasets used for analysis are available with this paper in S1 and S2 Files. Significance testing to compare the baseline and endline values using matched facility-level data was done using McNemar’s chi-squared tests for binary outcomes and Wilcoxon signed-rank test for continuous outcomes.

Results

In Uganda, a high proportion of focal facilities were already reporting routine provision of LARC services at baseline; 88% and 73% of facilities had provided implants and IUDs, respectively, within the last 90 days (Table 2). In Zambia, a lower percentage of facilities were routinely providing LARC services at the start of the program, with only 54% of facilities providing implants and 15% of facilities providing IUDs within the last 90 days at baseline. With the notable exception of IUD service provision in Zambia, most focal facilities were reporting providing LARC services on a routine basis (at least once within a 90-day period) prior to the introduction of the program in 2018, though due to the setup of HMIS reporting forms and DHIS2 reporting categories, it is not possible to ascertain the proportion of LARC services directly provided by government health facilities and health workers versus via INGO mobile clinical outreach teams. In contrast to relatively high baseline coverage of services, in both countries, the baseline assessment found notable gaps in availability of the supplies and equipment needed to provide implant and IUD services at these facilities (described below). The program first assessed service readiness and identified the gaps that might inhibit consistent availability or quality of services. Following baseline assessments, the program tracked service provision and service volumes to monitor trends in provision of services over time, with the expectation that both availability and provision of services would increase as more facilities were consistently equipped with required resources, as health worker confidence increased with mounting clinical experience, and as positive user experiences stimulated demand in communities.

Table 2. For key LARC program indicators in Zambia and Uganda.

Zambia Uganda
Data Baseline Midline Endline p-value1 Baseline Midline Endline p-value1
Service readiness 2
    % of program facilities with a trained provider in implant 60% (51/85) 74% (63/85) 92% (78/85) <0.001 84% (43/51) 94% (48/51) 98% (50/51) 0.008
    % of program facilities with a mentored provider in implant 9% (8/85) 87% (74/85) 99% (84/85) <0.001 53% (27/51) 94% (48/51) 98% (50/51) <0.001
    % of program facilities with a trained provider in IUD 54% (46/85) 76% (65/85) 92% (78/85) <0.001 45% (23/51) 100% (51/51) 96% (49/51) <0.001
    % of program facilities with a mentored provider in IUD 4% (3/85) 84% (71/85) 98% (83/85) <0.001 31% (16/51) 94% (48/51) 98% (50/51) <0.001
    % of program facilities with implant stock 86% (73/85) 73% (62/85) 62% (53/85) <0.001 84% (43/51) 94% (48/51) 98% (50/51) 0.008
    % of program facilities with IUD stock 38% (32/85) 62% (53/85) 39% (33/85) 0.862 61% (31/51) 92% (47/51) 94% (48/51) <0.001
    % of program facilities with tracer commodities/equipment for implants3 2% (2/85) 28% (24/85) 55% (47/85) <0.001 4% (2/51) 37% (19/51) 55% (28/51) <0.001
    % of program facilities with tracer commodities/equipment for IUDs4 12% (10/85) 29% (28/85) 38% (32/85) <0.001 10% (5/51) 71% (36/51) 65% (33/51) <0.001
Service provision 5
    % of program facilities that provided at least one implant in last 90 days6 54% (46/85) 60% (51/85) 68% (58/85) 0.023 88% (45/51) 92% (47/51) 96% (49/51) 0.103
    % of program facilities that provided at least one IUD in last 90 days6 15% (13/85) 39% (33/85) 32% (27/85) 0.004 73% (37/51) 73% (37/51) 92% (47/51) 0.012
    Number of implants provided at program facilities7 1,884 7,184 7,394 <0.001 4,560 10,346 23,463 <0.001
    Number of IUDs provided at program facilities7 251 4,384 3,866 <0.001 2,981 1,686 2,199 0.015
    % of CYPs generated by implants7 38% 47% 53% <0.001 48% 72% 82% <0.001
    % of CYPs generated by IUDs7 6% 35% 33% <0.001 43% 16% 12% 0.101

P values are based on a comparison of baseline and endline values using matched facility-level with McNemar’s chi-squared tests for binary outcomes and Wilcoxon signed-rank test for continuous outcomes.

All service readiness data points are from the facility assessment data. For Uganda, baseline was July 2018 and for Zambia baseline was September 2018. For both countries, midline was December 2019 and endline was December 2020.

Implant tracer commodities included: Implant, sterile gloves, betadine, cotton balls, lidocaine, and sterile drapes

IUD tracer commodities included: IUD, sterile gloves, sterile scissors, speculum, tenaculum, and sponge holding forceps

All service provision data points are from the national HMIS data.

For both countries, baseline was April to June 2018, midline was October to December 2019, and endline was October to December 2020.

For both countries, baseline was January to June 2018, midline was July to December 2019, and endline was July to December 2020.

Service readiness

At the start of the program in 2018, although most focal facilities in Uganda were providing both implants and IUDs routinely and most focal facilities in Zambia routinely provided implants, few focal facilities in either Uganda or Zambia had all human resources and supplies needed to provide implant and IUD services consistently without interruption (Table 2). In Uganda, the proportion of facilities that had a provider trained to provide implants increased from 84% at baseline to 98% at endline. This was coupled with an improvement in the availability of the required commodities and equipment to provide implants. Regarding service readiness for IUDs, 45% of LARC-eligible focal facilities had a provider trained to provide IUDs at the beginning of the program and this increased to 96% by the end of 2020. In the same period, commodity and equipment availability for providing IUDs increased substantially.

Similar trends were reflected in the Zambia program. The proportion of LARC-eligible focal facilities that had a provider trained to provide implants increased from 60% at baseline to 92% at endline. This was coupled with an improvement in the availability of all the required commodities and equipment to provide implants from 2% at baseline to 55% at endline. Regarding service readiness to provide IUDs, 54% of LARC-eligible focal facilities had a provider trained to provide IUDs at the beginning of the program and this increased to 92% by the end of 2020. In the same period, commodity and equipment availability for providing IUDs increased, though not as dramatically as in Uganda.

In both countries, the increase in the number of facilities that had a trained provider were smaller than the increase in facilities with all necessary commodities and equipment to provide LARCs. Importantly, the indicator on facilities with one staff member trained does not capture measurement of other improvements in health worker capacity achieved through having skills refreshed or having multiple staff members trained in a service area. In addition to training, on-the-job, post-training mentoring was also provided by government clinical mentors to health workers to support integration of skills into routine service delivery and drive provider confidence and quality of care. In Uganda, at endline, 98% of focal facilities had providers mentored to provide implants and IUDs, compared to only 53% and 31% respectively at baseline. In Zambia, 99% and 98% of focal facilities had providers mentored to improve implants and IUDs respectively at endline, compared to 9% and 4% at baseline.

Service provision

An increase in the number of implant and IUD services provided in both countries from 2018 to 2020 (Table 2) reflected the increase in number of facilities that met the minimum staffing and commodity requirements to provide LARCs in Uganda and Zambia, and that were also provided mentorship to support integration of skills into daily service delivery post-training.

As stated previously, coverage of service provision of LARCs in Uganda was relatively high at baseline; 88% of LARC-eligible focal facilities had provided at least one implant and 73% had provided at least one IUD in the last 90 days. At endline, LARC services were routinely provided at more eligible facilities; 96% of focal facilities had provided at least one implant and 92% had provided at least one IUD in the last 90 days. Across the focal facilities providing LARCs, the number of implants provided increased significantly from 4,560 at baseline to 23,463 at endline, but the number of IUDs provided decreased slightly from 2,981 at baseline to 2,199 at endline (not statistically significant) (Figs 2 and 3). As IUD volumes remained largely stable, implant volumes increased significantly, thus skewing the share of CYPs generated by LARCs firmly towards implants. Specifically, the CYPs generated by implants contributed an increasing share to the CYP method mix, from 48% in 2018 to 82% by the end of 2020. Conversely the share of the CYP method mix contributed by IUDs decreased from 43% to 12% in the same period. The overall share of CYPs generated by LARCs stayed largely constant over time, increasing slightly from 91% to 94% from baseline to endline.

Fig 2. Number of IUDs provided in program-supported sites in Uganda.

Fig 2

Fig 3. Number of implants provided in program-supported sites in Uganda.

Fig 3

In Zambia, 54% of LARC-eligible focal facilities had provided at least one implant and 15% had provided at least one IUD in the last 90 days at baseline. At endline, 68% of LARC-eligible facilities had provided at least one implant and 32% had provided at least one IUD in the last 90 days. These increases in the number of facilities providing LARC services were reflected in total service volumes for both methods. Implant service volumes increased from 1,884 at baseline to 7,394 at endline while IUD service volumes increased from 251 to 3,866 in the same period (Figs 4 and 5). As service volumes increased, the number of CYPs generated by implants contributed an increasing share to the CYP method mix from 38% to 53% by the end of 2020, while IUD CYPs accounted for 6% of the method mix at baseline and 33% of the method mix at endline.

Fig 4. Number of IUDs provided in program-supported sites in Zambia.

Fig 4

Fig 5. Number of implants provided in program-supported sites in Zambia.

Fig 5

Discussion

In both countries, the baseline assessment found notable gaps in the availability of the supplies and equipment needed to provide implant and IUD services, per current national clinical guidelines and protocols which provide guidance on the provision and quality assurance of LARC services. This was in contrast with the relatively high coverage of routine LARC provision at baseline. In both countries, INGO implementing partner mobile clinical outreach channels contributed to baseline service provision levels to an unknown degree. INGO outreach teams mobilized clients for services and travelled with trained clinicians and LARC supplies to provide LARC services per schedules agreed with facilities and local government. In Uganda, Marie Stopes International Uganda and Population Services International implemented family planning outreach activities to serve hard-to-reach rural communities with LARC and other FP services prior to the start of the program, and intermittently throughout the program lifetime. In Zambia, Marie Stopes was active in program geographies, and at the time of baseline data collection had recently started reporting into public sector facility registers. Outreach services are not disaggregated in HMIS forms or DHIS2, so it is not possible to confirm the extent to which outreach contributed to service volumes at baseline or throughout the program.

It was anticipated however that by improving routine availability of supplies and equipment and by strengthening human resource capacity, public sector facilities would be better able to meet demand for LARC services, decreasing reliance on implementing partner outreach. In enabling public sector facilities to better meet demand, this would then grow demand further as more clients have positive experiences accessing LARC services from public sector providers. As demand for LARC products grows, anecdotal evidence suggests that health worker confidence to provide services would increase, reinforcing a virtuous cycle of client demand and service availability.

While the interventions implemented in both Uganda and Zambia were similar, the details of the context and results achieved were different, contributing to complementary learnings.

Uganda

In Uganda, baseline facility assessments revealed significant gaps in availability of health workers trained to provide IUD services and supplies needed to provide IUD services. Assessments identified stock outs of ringed forceps, speculums, sponge holding forceps, and only 61% of facilities had actual IUDs in stock on the day of the assessment. Routine stock outs were attributed to inaccurate quantification, late product ordering and lack of earmarked budget at facilities or central government level to procure or replace missing equipment. Issues were noted around periodically low stock levels of IUDs due to delays in delivery of commodities to health centers and the fact that IUDs are currently excluded from the standardized basket of commodities that health center III facilities receive quarterly. Routine disruption in availability of key supplies required for IUD services continued throughout the program lifetime and likely enhanced existing preferences for implant insertion amongst trained health workers in Uganda. At the start of the program, less than half (45%) of focal facilities had an IUD-trained health worker, and only about a third (31%) of facilities had benefited from on-the-job mentoring on IUD provision. In contrast, most facilities (84%) had an implant-trained provider, and over half (53%) had benefitted from previous mentorship. It was anecdotally reported that health workers were more confident in implant insertion manual skills as a result of having had more practical experience in insertion of implants than IUDs and relatively few opportunities to practice IUD manual insertion skills under supervision or mentorship. Consequently, they counselled clients on methods they were most comfortable providing and on methods they felt able to provide given supply-related stock outs.

The program in Uganda was successful in strengthening key systems necessary for routine IUD provision but was unable to establish a virtuous cycle for IUD uptake. The program’s capacity building initiatives in collaboration with district health teams (described in Supporting Information File Table 1) led to nearly all (98%) focal facilities having a trained IUD provider, and due to improvements in accuracy of quantification, and more proactive emergency orders and redistribution of stock between focal facilities, most (65%) focal facilities had all the necessary supplies and commodities for IUD provision at endline. However, while the percent of program facilities that provided at least one IUD in the last 90 days increased from 73% to 92% by end of program, suggesting that IUD services were more consistently offered because of systems strengthening, the number of IUDs provided by focal facilities remained largely stable as seen in Fig 2. There was a non-statistically significant decrease of 26%, from 2,981 at baseline to 2,199 at endline, and within that time, IUD volumes dipped considerably lower at midline in 2019. Anecdotal feedback from government district health teams and CHAI program staff based in districts suggest that strong, prevalent myths and misconceptions circulating about IUDs, including linking IUD use to infertility and various cancers, as well as discomfort around how intra-uterine methods are inserted, meant that women were more inclined to choose implants as their preferred LARC option as both options became more routinely available. This likely contributed to a virtuous cycle for implant provision and uptake, where a greater number of satisfied users of public sector implant services emphasized the benefits of implants within their peer and social networks. Facilities were increasingly able to respond to existing demand for implants as the preferred LARC option, as demonstrated by a strong and largely consistent upward trend in implant services provided (Fig 3). As availability of high-quality implant services increased, more clients shared their positive experiences in their community, organically stimulating demand, which in turn strengthened health worker skills and confidence through frequency and repetition of implant insertion. This likely laid the groundwork for mobile clinical outreach teams deployed by Marie Stopes Uganda in program geographies to support lower-level facilities in meeting increased demand for implant services during periodic outreach events. Organic peer-to-peer dialogue and in-depth discussion between prospective clients, community members, and satisfied users was likely a critical enabler for implant mobilization and service volume growth. Conversely, IUD service provision was not stimulated in the same way. Prior to this public sector capacity building program, IUDs were largely provided during intermittent outreach events. Given the side effects non-hormonal IUDs are associated with, including menorrhagia, IUD users benefit from follow-up care and opportunities to discuss side effect management with health providers. However public sector health facilities were ill-equipped to provide routine follow-up counselling or to support side-effect management, and we hypothesize that limited capacity or readiness of public facilities to provide routine clinical follow up may have left contributed to negative user experiences, which in turn contributed to negative narratives. In Uganda, more concerted effort, targeted community sensitization and demand generation interventions would have likely been needed to jump start demand and interrupt existing negative narratives circulating in communities surrounding IUDs for which there was not a critical mass of existing demand that could be met by improving service readiness and provision. Unfortunately, due to the COVID-19 pandemic and related government-issued guidance on social distancing and limiting large gatherings, the program was unable to support implementation of some planned community mobilization and sensitization activities. While program-supported radio spots and shows continued to promote the benefits of FP in general and LARCs throughout the pandemic, a coordinated campaign of more facilitated face-to-face sensitization events which leverage peer to peer mobilizers and satisfied users may have effectively tackled entrenched myths and misconceptions about IUDs in target geographies, but opportunities for this were limited.

Zambia

In Zambia, baseline assessments confirmed significant gaps in contraceptive commodities. Availability of implants and IUDs continued to vary significantly throughout the program in Zambia due to insufficient government funding for commodity procurement, exacerbated by the mounting fiscal pressures of the COVID-19 pandemic response. Severe fiscal challenges across government ministries led to reductions in national health programs and insufficient funding for the national drug budget. Routine stockouts of LARC commodities as well as other LARC-related supplies were also attributed to lack of sufficient funding for transport between central level warehouses, district hubs and facilities, making it difficult to deliver products to districts and facilities per set schedules. Exacerbating these challenges, Zambia (as well as Uganda) was impacted by global level manufacturing capacity constraints for contraceptive implants, which pre-dated and continued throughout the program, further contributing to inconsistent availability and consumption of one-rod implant Implanon NXT and two-rod implant Jadelle, as well as contributing to challenges in accurate facility-level forecasting for implants. Finally, inconsistent documentation of services provided by health workers within facility service registers in Zambia made it difficult for facilities and districts to interpret past consumption and create data-based forecasts to inform future orders. These significant financing and supply chain systems challenges resulted in variability in availability of implant and IUD commodities; whereas 86% of eligible facilities had implants in stock on the day of the assessment at baseline, only 62% of focal facilities had implants in stock at endline, and there was no notable change in IUD stock availability over the course of the program. Commodity stock outs therefore likely had a dampening effect on overall service volume growth observed. Despite this, the program in Zambia was able to improve routine availability and provision of both implant and IUD services at focal facilities as observed through the increase in facilities providing implants (from 46 to 51 facilities) and IUDs (from 13 to 33 facilities) within the last 90 days from baseline to midline. This was accomplished by addressing systems-level barriers to service provision including capacity of health workers. At baseline only 60% and 54% of focal facilities had providers trained on implant and IUD provision respectively; this increased to 92% at endline. Trained providers then received government-led on-the-job mentoring to support integration of skills into service delivery.

As in Uganda, the program in Zambia supported enhanced readiness of facilities to provide services. Awareness of LARC options and benefits amongst potential users improved, which launched a virtuous cycle of supply and demand for LARC methods, demonstrated by a steady upward trend in implant and IUD services provided by focal facilities over time as seen in Figs 4 and 5. A notably significant increase in both IUD and implant volumes was observed in Q3 2019, when Zambia received an influx of LARC commodities from global procurers, and service provision volumes continued to increase over time, though volumes were variable due to the impacts of commodity stock outs. We believe this demonstrates that health worker capacity building and systems strengthening efforts were largely successful in increasing readiness to provide the service amongst focal facilities, enabling facilities to respond to existing and growing demand for these services (subject to commodity availability).

In contrast to Uganda, the program in Zambia appeared to have kick-started a virtuous cycle of supply and demand for IUDs. There are important points of difference to note between the Uganda and Zambia contexts which may help explain this. First, baseline IUD service provision and associated volumes reported were relatively low in Zambia providing more scope for growth; per program data, only 15% (13/85) of eligible facilities routinely reported providing IUDs at the start of the program. Second, the percent of women who have ever heard of the IUD as a contraceptive method was relatively low in program geographies in Zambia at baseline; according to Zambia’s 2018 Demographic and Health Survey, in Northern Province, only 51.2% of women were aware of the IUD as a contraceptive, which is low compared to awareness at the national level in Zambia (63.6%) [19] and as compared to awareness of IUDs in the program regions of North Buganda and Bunyoro in Uganda (87.2%) [20]. Anecdotal reports from stakeholders indicated that in Uganda, previous IUD service provision by outreach teams without investment in public sector capacity to provide IUD side effect management and follow up care may have contributed to a cycle of low IUD provision and use. By contrast, in Zambia, health workers and users had limited experiences, both positive and negative, with IUDs. Strong opinions against the method amongst community members and key opinion leaders may have therefore been less fully formed. Over the program lifetime the percent of facilities that had provided IUDs within the last 90 days doubled to 32%, and the average monthly consumption of IUDs increased from 42 to 644 by endline. From July 2019, following an influx of LARC commodities to Zambia, INGO Marie Stopes Zambia restarted implementation of partner outreach events after having paused due to commodity shortages and in similarity with Uganda, mobile clinical outreach units deployed by INGOs to program geographies also responded to and met increased demand for LARC services generated by government health workers and community mobilization structures.

Role of COVID-19 pandemic

With regards to the impact of the COVID-19 pandemic on program implementation and results, as observed in Table 2, by the end of 2019, immediately prior to the start of the COVID-19 pandemic, both programs had observed significant increases in the proportion of LARC-eligible focal facilities with a provider trained to provide implants and IUDs and in the proportion of focal facilities with tracer commodities and equipment for implant and IUD services, with the caveat that in Zambia, IUD and implant provision dipped from Q4 2019 primarily due to fiscal challenges which led to stockouts of LARC commodities. Following improvements in service readiness, from midline focal facilities reported significant growth in service volumes, with the exception of IUD services in Uganda. It should be noted that from March 2020, the global COVID-19 pandemic increasingly impacted health service provision and health seeking behavior in both countries. To mitigate the impact of the pandemic and sustain previous gains in service readiness, both programs worked with subnational government teams to activate informal channels for communication, enabling remote mentorship through instant messaging applications during which government mentors reinforced the importance of continuity of LARC service provision and facility managers solved for LARC-related supply issues in real time. Apart from increased stock outs of implants and IUDs in Zambia in 2020, both programs maintained and built on progress made pre-pandemic to increase readiness of focal facilities to provide LARC services. In both countries, to mitigate the impact of the pandemic on demand for routine contraceptive services, programs supported the procurement of Personal Protective Equipment (PPE) for community health workers to enable them to promote hand washing, social distancing, and mask wearing while continuing to mobilize demand for contraception. Community health workers were provided with information to allay community fears related to visiting health facilities and perceived increased risk of catching COVID-19.

Recommendations

Based on the experience of this program, we believe that systems-strengthening to improve service readiness is a key input to establishing a virtuous cycle for LARCs where client demand and provider skills, comfort, and confidence are mutually reinforcing. Capacity building to improve service readiness must be rationally sequenced with interventions to ensure supply and increase client demand for LARC methods so as to support health worker skills development and integration into routine service delivery. When a virtuous supply and demand cycle is in place, there is: accurate information on LARCs circulating amongst communities, increasing client demand; high provider skills acquisition, skills retention and buy-in; high provider comfort and confidence to counsel or provide the service; accurate, high-quality counseling by health workers; and consistent supply available of LARC commodities. Information and experiences are shared by word of mouth from one satisfied or dissatisfied user to her peers, and it is critical that LARC scale-up interventions are designed to interrupt negative narratives and establish positive narratives surrounding both implants and IUDs. This is particularly true for IUDs, for which intransigent myths and misconceptions related to risks of infertility, cancer, and other long-term health consequences significantly impact demand, as observed in Uganda.

There is increasing interest in and recognition of the role of the public sector in increasing access to and equity in family planning services [21]. Implementation experience suggests that in order to rapidly improve the readiness of public sector facilities to provide LARC services, a number of initial investments are likely to be needed to catalyze the cycle of supply and demand for implants and IUDs. Both programs used donor funding to enable government-led training and mentorship and procure and distribute missing equipment needed for LARC service provision which resulted in rapid activation of facilities as access points for LARC services. Catalytic interventions, including traditional implementing partner supported mobile clinical outreach, can and should be linked to broader systems strengthening interventions, and where possible should seek to complement or help to facilitate commitment of subnational government resources to the implementation of program interventions. In both Uganda and Zambia, subnational government leadership have now integrated LARC clinical mentorship into SRMNH operational plans and budgets, with local governments making in-kind and financial commitments to the continuity of clinical mentorship. This suggests that subnational government structures and public health facilities may be able to take on more of the contraceptive-related program activities traditionally led by implementing partners and funded by international donors, integrating these to some extent into domestic budgets and plans. Strengthening government-owned supply chain systems to ensure availability of LARC commodities at facilities, while in tandem strengthening training and mentoring for health workers, is essential for enabling increased LARC service provision and use in the public sector. In parallel, barriers to demand must be meaningfully addressed, and further operational research to demonstrate cost-effective, sustainable, and scalable approaches to community mobilization and social and behavior change communication is needed to inform government and partner approaches as health system capacity increases. We recommend drawing from program learnings around the importance of using a systems lens to create a virtuous cycle of supply and demand when implementing aimed at increasing availability and voluntary uptake of LARCs and other family planning services in Uganda, Zambia, and comparable market contexts.

Limitations

There are several limitations to this analysis and discussion of the program. The service delivery data reported by facilities includes LARC services provided at each site by public sector staff as well as by visiting INGO teams. It is not possible to ascertain the proportion of LARC services directly provided by government health workers versus INGO mobile clinical outreach teams, however INGO activities and investments were not reported to change substantially over this program period. Due to the COVID-19 pandemic, facility assessments were largely conducted over the phone in 2020 and facilities self-reported data. However, as there were no direct benefits or risks of honest reporting, we believe that this presents minimal risk of bias. The definition for the indicator that measured the percent of facilities with tracer commodities and equipment for IUDs excluded uterine sounds from facility assessment checklists. Uterine sounds are used where transvaginal ultrasound is not available to ascertain uterine depth and this equipment is required for routine IUD insertion. Availability of uterine sounds for IUD provision in focal facilities is therefore unknown. In Uganda, data for the indicator that measured the percent of focal facilities with a trained and mentored provider in IUD provision was not collected at baseline; baseline data used represents the proportion of focal facilities with a provider trained and mentored in post-partum IUD provision. With respect to service provision data, the program reviewed and cleaned data pulled from HMIS, investigating any outliers. However, HMIS data may be subject to unknown reporting errors. In routine HMIS data, it is not possible to separate the services provided through INGO outreach from routine service provision at facilities. Facility catchment areas and related number of households served changed during the program due to changes in local administrative zones in Uganda and Zambia, although the positive trend in overall service growth suggests the program largely mitigated the impact of these changes. Lastly, both implants and IUDs can be inserted immediately post-partum. Both programs aimed to increase access to post-partum LARC services through improving quality of health education and counselling during antenatal care and documentation within client records to indicate choice of optional post-partum contraception, however post-partum LARC results and learnings are outside the scope of this paper.

Conclusions

Technical assistance partners, local government units, and health managers must work together to improve the availability of LARC products and services in eligible public sector facilities. Rapid increases in readiness of facilities to provide services can be achievable when a combination of catalytic and systems strengthening interventions are deployed. Whereas traditional investments in LARC scale-up have leveraged INGO service delivery partners to fill gaps in public sector capacity and personnel to provide LARCs, this program in Uganda and Zambia demonstrated that the public sector can be rapidly capacitated to provide LARC services. Implemented collaboratively, partner-supported outreach channels may be able to help establish a virtuous cycle of LARC provision in the public sector by supporting the public sector to meet rapidly growing demand for LARC services. With respect to IUD scale up however, it is important that catalytic INGO outreach is implemented in tandem with public sector health systems strengthening, to ensure public sector facilities can provide high quality counselling and management as part of follow up care. By supporting clients with management of side effects, public sector facilities can support positive client IUD experiences, and contribute to positive narratives about IUDs in communities. To increase public sector capacity for LARC service provision, government systems must be strengthened to bolster health workforce management, health worker capacity building, supply chain management, and community mobilization simultaneously.

Supporting information

S1 Table. Key LARC-related program activities.

This table includes the LARC-related activities implemented by government and CHAI in Uganda and Zambia in this program.

(DOCX)

S1 File. Uganda datasets.

(XLSX)

S2 File. Zambia datasets.

(XLSX)

Acknowledgments

We would like to express our deep gratitude to the women, families, and health workers of Kagadi, Kakumiro, Kassanda, Kibaale, Mityana, and Mubende districts in Uganda and Northern Province in Zambia for their engagement in this work. This paper reflects effort from countless individuals, but we would like to recognize the partnership and contributions of key Ministry of Health staff that supported implementation of this program: Dr. Jesca Nsungwa Sabiiti in Uganda and Beauty Muntanga, the late Lissah Susiku, Dr. Lawrence Phiri and Maxwell Kasonde in Zambia. We would also like to thank CHAI staff that were invaluable in developing strategy and implementation of the program: Rosette Birungi, Manish Burman, Ronald Kizito, Refilwe Kotane, Kelly McCrystal, Robyn Churchill, Waza Mhango, Levy Mkandawire, Helen Mwiinga, Racheal Najjemba, Flavia Namayengo, Mindy Scibilia, Monica Setaruddin, Margaret Siame, Andrew Storey, Lawrence Were, and Rabson Zimba.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

This work was made possible with financial support from The ELMA Foundation and an anonymous donor (grants received and managed by HS and AM). The views expressed in this report are the opinions of the authors, and do not necessarily reflect the official policies of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

Decision Letter 0

Lea Sacca

29 Mar 2023

PONE-D-23-00410Strengthening systems to provide Long-Acting Reversible Contraceptives (LARCs) in public sector health facilities in Uganda and Zambia: Program results and learningsPLOS ONE

Dear Dr. Aldrich,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 13 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Lea Sacca

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  

Please find more information on the policy and a link to download a blank copy of the questionnaire here:

https://journals.plos.org/plosone/s/best-practices-in-research-reporting.

Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

3. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

4. Thank you for stating in your financial disclosure:  

"This work was made possible with financial support from The ELMA Foundation and an anonymous donor (grants received and managed by HS and AM). The views expressed in this report are the opinions of the authors, and do not necessarily reflect the official policies of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

PLOS ONE requires you to include in your manuscript further information about the funder so that any relevant competing interests can be assessed. Please respond to the following questions:

1) Please state whether any of the research costs or authors' salaries were funded, in whole or in part, by a tobacco company (our policy on tobacco funding is at http://journals.plos.org/plosone/s/disclosure-of-funding-sources)  

2) Please state whether the donor has any competing interests in relation to this work (see http://journals.plos.org/plosone/s/competing-interests) . 

3) Please state whether the identity of the donor might be considered relevant to editors or reviewers’ assessment of the validity of the work.

4) If the donors have no perceived or actual competing interests, please state: “The authors are not aware of any competing interests”. 

This information should be included in your cover letter. We will amend your financial disclosure and competing interests on your behalf.

5. Please ensure that you refer to Figures 2 to 5 in your text as, if accepted, production will need this reference to link the reader to the figure.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Comments to the Author

Abstract

• Give a brief introduction/definition and examples of the Long acting reversible contraceptives (LARCs) in Uganda and Zambia

• Define readiness since it’s a key word under methods

• Under methods, quote which indicators were monitored and why? Is that they are recommended by MoH/WHO/CDC?

Introduction

• Begin with defining unintended pregnancies at the beginning

• Show the commitment of Uganda and Zambia to increase access to family planning services either by MOH policies or strategic plans. Quote and cite them

• Give a paragraph describing and discussing supply-demand factors before paragraph two

• Before describing the efforts of NGOs (paragraph 3), talk about government efforts to promote access and utilization of LARCs. This should preceed before the INGOs efforts

• Give a full paragraph describing this programme which was implemented in Uganda and Zambia. Be clear on how it supplemented Public/government of Uganda efforts, quote the indicators which we were interested in but also the interventions which were undertaken

Methods

• Describe the districts/hospitals that participated

• Mention the number(s) of interventions and clearly show a distinction beyond government efforts because you stand a risk of failing to attribute the results we see to your efforts

• Describe how different this LARC programme was designed, implemented, monitored. Make these sections clearly stated

• Under setting, give the population profiles for Uganda and Zambia. Quote the implementing efforts/initiatives in the two countries like Maries Stopes, UNFPA and so forth. Quote the statistics as much as you can. You can cite the UDHS survey 2022

• For baseline assessment, clearly mention how it was done, by who? Which indicators did we focus on? How did we measure this? Which tools did we use? What informed this baseline? Did we use standard tools? Etc

• Mention the names of IRBs that reviewed your protocols and dates of approvals

Results

• Try to have some factors that could explain the high uptake in Zambia than in Uganda? Try to run factors associated and we could see what to leverage on from Zambia for Uganda

• For us to make a good case, try to show the statistics of our indicators three years before our intervention such that we can see a change during your intervention period

Discussion

• Break the first paragraph into different sections. It’s long. Begin with a preamble of what we found out

• Support your assertions with existing international literature like USA, UK,China etc

• Discuss the contributions of other NGOs like Marie Stopes, UNFPA, USAID RHITES and so forth

• Align with MoH Policies and guidelines

Conclusions and recommendations

• Clearly give these findings with MoH guidelines/strategic plans/policies

• What are you telling implementing partners on your results

• What does this imply for National Medical stores and Joint Medical stores

• What are the areas for future research?

• What are the implications of these results to SDGs and national strategic plans in the two countries

Reviewer #2: Strengthening systems to provide Long-Acting Reversible Contraceptives (LARCs) in public sector health facilities in Uganda and Zambia: Program results and learnings.

Summary.

The authors conducted a study looking at strengthening systems to provide Long-Acting Reversible Contraceptives (LARCs) in public sector health facilities in Uganda and Zambia: Program results and learnings.

This study is significant and applicable to both study settings as there is a high rate of unintended pregnancies. The article is generally well written, but the following points need to be considered:

1. The contextual differences or similarities between the two countries/study sites should be explained. This is crucial because it will enable a better understanding of the variations in project intervention uptake, such as the use of intrauterine devices (IUDs). The discussion's elaborated contextual explanations are insufficient. The authors might also consider other social and cultural aspects that have been covered in other works of literature.

2. The authors ought to explain why particular provinces in the two countries were chosen. How does the provision of sexual, reproductive, maternal, and new-born health (SRMNH) in each nation compare on a provincial level?

3. The authors must describe the type/category of health professionals trained at these facilities. Discuss how the project dealt with staff attrition throughout the course of the study as well.

Minor comments

1. Provide a reference for Figure 1. Virtuous cycle of LARC availability and provision.

2. In the discussion section first paragraph “In Zambia, Marie Stopes Zambia was active in Zambian program geographies, and at the time of baseline data collection had recently started reporting into public sector facility registers.” Rephrase to avoid text redundancy

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Abel Wilson Walekhwa

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewer.pdf

PLoS One. 2023 Aug 18;18(8):e0290115. doi: 10.1371/journal.pone.0290115.r002

Author response to Decision Letter 0


27 Jun 2023

Reviewer #1 comments

Abstract

1. Give a brief introduction/definition and examples of the Long acting reversible contraceptives (LARCs) in Uganda and Zambia.

Response: Thank you for this suggestion. We added the following underlined text to the first sentence of the abstract to further define LARCs.

“In Uganda and Zambia, both supply- and demand-side factors hamper availability of long-acting reversible contraceptives (LARCs), including implants and intrauterine devices (IUDs), at public sector facilities.”

2. Define readiness since it’s a key word under methods

Response: Thank you for this point. We’ve defined readiness further in the Key Indicators section with the following text:

“We define readiness as the presence of the necessary commodities, equipment, and trained staff to provide a specific service”

3. Under methods, quote which indicators were monitored and why? Is that they are recommended by MoH/WHO/CDC?

Response: In an effort to maintain the journal word limit for the abstract, we have not described the indicators in detail in the abstract; however, the indicators are listed in Table 1. We also added the following underlined text to respond to the request for clarification about who agreed to or recommended the indicators:

“In relation to LARCs, several key indicators were agreed upon at the outset of the program by program and government staff as a foundation to align all stakeholders around strategic goals and measures of success (Table 1).”

Introduction

4. Begin with defining unintended pregnancies at the beginning

Response: We have added the following sentence to define unintended pregnancies:

“Unintended pregnancies are pregnancies that are mistimed, unplanned or unwanted at the time on conception.”

5. Show the commitment of Uganda and Zambia to increase access to family planning services either by MOH policies or strategic plans. Quote and cite them

Response: Thank you for this comment. We have added the following underlined text to demonstrate the commitment of both governments to expanding access to family planning services:

“In Uganda and Zambia, high numbers of unintended pregnancies contribute to high rates of morbidity and mortality due to unsafe abortion and lack of access to routine and emergency obstetric care. The governments of Uganda and Zambia are committed to increasing access to and use of modern family planning (FP) to reduce unintended pregnancies and maternal morbidity and mortality. For example, the Zambian National Health Strategic Plan of 2022 – 2026 commits to increase the proportion of women of reproductive age (aged 15–49 years) who have their need for family planning satisfied with modern methods from 68.5% in 2018 to 80% 2026 [1], and in Uganda, government seeks to increase the modern contraceptive (mCPR), for all women, from 30.4% in 2020 to 39.6% by 2025 and reduce the unmet need for modern contraception from 17% in 2020 to 15% by 2025[2]”

6. Give a paragraph describing and discussing supply-demand factors before paragraph two

Response: Thank you for highlighting this. The supply and demand side issues are described as follows:

“Public sector supply-side gaps include insufficient numbers of trained health workers skilled to provide LARC services, persistent gaps in LARC commodities at service delivery points, and lack of essential equipment, medicines and supplies to provide LARCs. At the same time, demand-side issues related to family planning include lack of awareness of LARC benefits and pervasive myths and misconceptions about implants and IUDs limit demand for family planning…”

7. Before describing the efforts of NGOs (paragraph 3), talk about government efforts to promote access and utilization of LARCs. This should precede before the INGOs efforts

Response: We have added information about the key government commitments in the family planning space that provide a foundation for all programming. The additional text is as follows:

“The Zambian and Uganda governments are working to address these issues and expand access to family planning, including LARCs. In Zambia, the government pledged to invest $12 million in family planning programs in 2023, with yearly increases of 30% after that [13]. In Uganda, the government has committed to ring fence 50% of the domestic reproductive health commodities budget for procurement, storage and distribution of FP commodities from by 2025 [14].”

8. Give a full paragraph describing this programme which was implemented in Uganda and Zambia. Be clear on how it supplemented Public/government of Uganda efforts, quote the indicators which we were interested in but also the interventions which were undertaken

Response: Thank you for highlighting this. The purpose of Supplemental Table 1 is to provide detailed descriptions of the program activities. Upon reflection on this comment, we realized that the reference to S1 Table was perhaps not descriptive or clear enough to guide readers, so we have added the following text to provide more information. This text also addresses the question of how these activities supplement the governmental efforts.

“The program activities relating to LARCs that were implemented in Uganda and Zambia by CHAI and the government are described in detail in S1 Table. Though the activities were implemented with government collaboration, these activities were beyond and in addition to the routine service support activities performed by the government.”

Methods

9. Describe the districts/hospitals that participated

Response: Thank you for this comment. We agree that more contextual information is useful, and we have added the following text in the Setting section in response:

“These areas of Zambia and Uganda were selected by the government as the focal area for this work because they were some of the most underperforming areas of the country on SRMNH-related outcomes, Northern Province, Zambia is a very rural and hard-to-reach areas with no other maternal and newborn health programs active in the province at the time that this program was launched. The selected districts in Uganda area are within several hours drive from the capital of Uganda, Kampala, but nonetheless include areas that are hard-to-reach due to poor road networks.”

10. Mention the number(s) of interventions and clearly show a distinction beyond government efforts because you stand a risk of failing to attribute the results we see to your efforts

Response: Thank you for this comment, which seems closely related to the point above in comment #8. As noted above, we have added the following text to guide readers to S1 Table where the program activities are described in more detail.

“The program activities relating to LARCs that were implemented in Uganda and Zambia by CHAI and the government are described in detail in S1 Table. Though the activities were implemented with government collaboration, these activities were beyond and in addition to the routine service support activities performed by the government.”

11. Describe how different this LARC programme was designed, implemented, monitored. Make these sections clearly stated

Response: We have added the following text to provide more information about the program:

“The program was designed by CHAI and the MOHs, building on previous experience of both groups and with careful consideration and adaptation for the local context and opportunities. CHAI developed a standardized mentorship framework and implementation package to assist focal geographies to address systems and facility-level barriers to SRH access, provision, and uptake. This assisted in addressing the gaps in LARC service provision. CHAI leveraged the pool of family planning government trainers and mentors to build health care worker capacity and drive acknowledgement amongst community traditional leadership of the need to scale up awareness of the benefits of family planning.”

12. Under setting, give the population profiles for Uganda and Zambia. Quote the implementing efforts/initiatives in the two countries like Maries Stopes, UNFPA and so forth. Quote the statistics as much as you can. You can cite the UDHS survey 2022

Response: Thank you for these questions. We agree that national statistics provide critical context for the program and results. National statistics on contraceptive use are provided in the introduction section. With regards to activities of other implementing partners, we describe the activities of Marie Stopes International in both Uganda and Zambia and of Population Services International in Uganda within the Discussion section.

13. For baseline assessment, clearly mention how it was done, by who? Which indicators did we focus on? How did we measure this? Which tools did we use? What informed this baseline? Did we use standard tools? Etc

Response: Thank you for these questions. We have added the following underlined text to the Methods section to clarify the approach to the facility assessments:

“Facility assessments were conducted in Uganda and Zambia to determine which facilities had the resources and capacity to provide LARCs and other SRMNH services. The facility assessments were conducted by program staff or contractors using tools developed by the program to track the intended program indicators (Table 1) on family planning and other topics. The baseline assessment was conducted in July and August 2018 for Uganda and Zambia, respectively. ...”

14. Mention the names of IRBs that reviewed your protocols and dates of approvals

Response: This paper covers data from two different sources and the review process was tailored for each. The facility assessment process where primary data was collected by this program was reviewed by IRBs in both countries, as described in this text. We have added the date of review in response to this comment:

“The facility assessments were approved by ethical review committees in both countries in July 2018, including the ERES Converge Institutional Review Board (IRB) in Zambia (reference number 2018-Jul-017) the AIDS Support Organization IRB in Uganda (reference number 026/18-UG-REC-009). The IRBs determined that this work did not engage human subjects and that patient consent was not required.”

The routine service delivery data in aggregate data and its analysis was determined not to engage human subjects. We added the following text to clarify this:

“This data is available in aggregate form without any individualized patient information, and as a result, this work was determined by CHAI’s internal Scientific and Ethical Review Committee to not engage human subjects or require patient consent.”

Results

15. Try to have some factors that could explain the high uptake in Zambia than in Uganda? Try to run factors associated and we could see what to leverage on from Zambia for Uganda

Response: This point raises an important issue that we have discussed at length internally and would like to shed light on in the paper. We feel that this type of consideration of the results is more appropriate though for the Discussion section as opposed to the Results. The paragraph in the Discussion that begins with the following is an effort to consider the factors that made the experience of these two countries different.

“In contrast to Uganda, the program in Zambia appeared to have kick-started a virtuous cycle of supply and demand for IUDs. There are important points of difference to note between the Uganda and Zambia contexts which may help explain this.”

16. For us to make a good case, try to show the statistics of our indicators three years before our intervention such that we can see a change during your intervention period

Response: We agree that tracking trends over a longer period of time is preferable, but unfortunately, it is not possible in this case. The data from the facility assessments was collected by the program, beginning with the baseline assessment at the start of the program. We are not aware of any other dataset that tracks similar data on a consistent basis across the program-supported sites. The routine service delivery data is captured by facility staff in an on-going way, but during the program period, program staff were regularly engaging with government officials to review data and perform quality checks. We routinely identified data entry errors in the DHIS2 data system and program staff proactively followed MOH guidelines to have errors investigated and corrected. Because this data quality assurance process was performed only on data from 2018 forward, the data from prior years would not be comparable and may be misleading.

Discussion

17. Break the first paragraph into different sections. It’s long. Begin with a preamble of what we found out

Response: We have broken out the first paragraph of the discussion into two smaller paragraphs and we hope that this improves readability.

18. Support your assertions with existing international literature like USA, UK, China etc

Response: We appreciate and resonate with this comment. We reviewed available literature for comparable market contexts, specifically low-income, low-resource settings in Africa. Public sector health systems strengthening interventions with a focus on systems for delivering long-acting reversable contraception are under-documented in the relevant contexts. We reflected this in the Introduction where we note that neither implementation experiences nor evaluations of the effectiveness of public sector strengthening programs have been widely documented.

19. Discuss the contributions of other NGOs like Marie Stopes, UNFPA, USAID RHITES and so forth

Response: Thank you for this comment. We agree it is important to recognize the contributions of other implementing partners. UNFPA is active in both Uganda and Zambia at the national level, supporting among other things national supply chain program management. UNFPA has not be an active implementer at the subnational level in program geographies in either country. We describe the activities of Marie Stopes International and Population Services International in the Discussion section: ‘’In Uganda, Marie Stopes International Uganda and Population Services International implemented family planning outreach activities to serve hard-to-reach rural communities with LARC and other FP services prior to the start of the program, and intermittently throughout the program lifetime. In Zambia, Marie Stopes was active in program geographies, and at the time of baseline data collection had recently started reporting into public sector facility registers. Outreach services are not disaggregated in HMIS forms or DHIS2, so it is not possible to confirm the extent to which outreach contributed to service volumes at baseline or throughout the program.’’ The program focal districts in Uganda were not covered by USAID RHITES.

20. Align with MoH Policies and guidelines

Response: Thank you for this important comment and point. Eligibility and requirements for the provision of LARC services by the public sector are outlined in the national Uganda Clinical Guidelines and national Zambia Family Planning Guidelines and Protocols documents, as described in the Setting section. Program and government staff aligned at the outset of the program on strategic goals and measures of success (Table) which was informed by the eligibility criteria for LARC provision as set out in national guidelines. The data presented and discussed in the paper is therefore a reflection on the health system’s capacity to meet standards and guidelines and provide quality LARC services in line with existing government guidance. We appreciate this may not have been clear to the reader, and have added the underlined text to the Discussion section: ‘’In both countries, the baseline assessment found notable gaps in the availability of the supplies and equipment needed to provide implant and IUD services, per current national clinical guidelines and protocols which provide guidance on the provision and quality assurance of LARC services.’’

Conclusions and recommendations

21. Clearly give these findings with MoH guidelines/strategic plans/policies? What are you telling implementing partners on your results? What does this imply for National Medical stores and Joint Medical stores? What are the areas for future research? What are the implications of these results to SDGs and national strategic plans in the two countries

Response: Thank you for these questions. Results and recommendations were widely disseminated through national technical working groups chaired by MOHs and attended by key implementing partners at the conclusion of the program. At the subnational level, provincial/district leadership reviewed program results and aligned on changes to local government operational plans and budgets. Key recommendations shared with implementing partners and recommendations taken forward by subnational governments are described in the Recommendations section: ‘’Implementation experience suggests that in order to rapidly improve the readiness of public sector facilities to provide LARC services, a number of initial investments are likely to be needed to catalyze the cycle of supply and demand for implants and IUDs. Both programs used donor funding to enable government-led training and mentorship and procure and distribute missing equipment needed for LARC service provision which resulted in rapid activation of facilities as access points for LARC services. Catalytic interventions, including traditional implementing partner supported mobile clinical outreach, can and should be linked to broader systems strengthening interventions, and where possible should seek to complement or help to facilitate commitment of subnational government resources to the implementation of program interventions. In both Uganda and Zambia, subnational government leadership have now integrated LARC clinical mentorship into SRMNH operational plans and budgets, with local governments making in-kind and financial commitments to the continuity of clinical mentorship. This suggests that subnational government structures and public health facilities may be able to take on more of the contraceptive-related program activities traditionally led by implementing partners and funded by international donors, integrating these to some extent into domestic budgets and plans.’’

To further expand upon recommendations we have added the following additional text: ‘’Strengthening government-owned supply chain systems to ensure availability of LARC commodities at facilities, while in tandem strengthening training and mentoring for health workers, is essential for enabling increased LARC service provision and use in the public sector. In parallel, barriers to demand must be meaningfully addressed, and further operational research to demonstrate cost-effective, sustainable, and scalable approaches to community mobilization and social and behavior change communication is needed to inform government and partner approaches as health system capacity increases. We recommend drawing from program learnings around the importance of using a systems lens to create a virtuous cycle of supply and demand when implementing aimed at increasing availability and voluntary uptake of LARCs and other family planning services in Uganda, Zambia, and comparable market contexts.’’

Reviewer #2 comments

Summary: The authors conducted a study looking at strengthening systems to provide Long-Acting Reversible Contraceptives (LARCs) in public sector health facilities in Uganda and Zambia: Program results and learnings. This study is significant and applicable to both study settings as there is a high rate of unintended pregnancies. The article is generally well written, but the following points need to be considered:

1. The contextual differences or similarities between the two countries/study sites should be explained. This is crucial because it will enable a better understanding of the variations in project intervention uptake, such as the use of intrauterine devices (IUDs). The discussion's elaborated contextual explanations are insufficient. The authors might also consider other social and cultural aspects that have been covered in other works of literature.

Response: Thank you for this comment. Similarities in the health of the population were observed through review of maternal and newborn health indicators, with the chosen program regions scoring amongst the lowest comparatively. We note a number of important points of difference between the Uganda and Zambia contexts which may help explain the difference in results observed, including: ‘’Anecdotal reports from stakeholders indicate that in Uganda, previous IUD service provision by outreach teams without investment in public sector capacity to provide IUD side effect management and follow up care may have contributed to a cycle of low IUD provision and use. By contrast, in Zambia, health workers and users had limited experiences, both positive and negative, with IUDs. Strong opinions against the method amongst community members and key opinion leaders may have therefore been less fully formed.’’ We observed broad similarities across the common myths and misconceptions circulating in communities about LARCs, but found these were easier to shift in Zambia, in part likely due to the reasons stated above. We feel that a broader exploration of socio-cultural differences that impacted results may be beyond the scope of this paper, though agree that social-cultural enablers and barriers to family planning use are necessary to consider when designing holistic interventions to address both supply and demand side factors and have added an additional recommendation around the need for further operational research to demonstrate cost-effective, sustainable, and scalable approaches to community mobilization and social and behavior change communication (see response to question 21 above).

2. The authors ought to explain why particular provinces in the two countries were chosen. How does the provision of sexual, reproductive, maternal, and new-born health (SRMNH) in each nation compare on a provincial level?

Response: Thank you for this comment. We agree that more contextual information is useful and we have added the following text in the setting section in response:

“These areas of Zambia and Uganda were selected by the government as the focal area for this work because they were some of the most underperforming areas of the country on SRMNH-related outcomes, Northern Province, Zambia is a very rural and hard-to-reach areas with no other maternal and newborn health programs active in the province at the time that this program was launched. The selected districts in Uganda area are within several hours drive from the capital of Uganda, Kampala, but they nonetheless include areas that hard-to-reach.”

3. The authors must describe the type/category of health professionals trained at these facilities. Discuss how the project dealt with staff attrition throughout the course of the study as well.

Response: Thank you for this comment. We have added the following text in the program approach section to address this point:

“Training and mentorship was offered to cadres eligible to provide LARC services in each country, with a focus on nurses, midwives, and clinical officers. Facilities with trained HCWs received on-the-job mentoring. Mentorship helped to institutionalize skills within facilities and benefitted multiple health workers beyond those that were trained formally by the program. While mentoring may have helped to cascade skills and mitigate impacts of staff transfers, provider attrition was a reality the program had to contend with. The program coordinated with local leadership to rationalize staff transfers and ensure coverage of trained health workers at program sites. Trained health workers were encouraged to provide on-the-job training to other health workers in their facilities to ensure the availability of services in the event of attrition.”

Minor comments

4. Provide a reference for Figure 1. Virtuous cycle of LARC availability and provision.

Response: Thank you for requesting this clarification. The content of Figure 1 was developed by this program. We have added the following text to the paper to make that clear:

“Figure 1 depicts a virtuous cycle for LARC introduction as developed and used by this program.”

5. In the discussion section first paragraph “In Zambia, Marie Stopes Zambia was active in Zambian program geographies, and at the time of baseline data collection had recently started reporting into public sector facility registers.” Rephrase to avoid text redundancy

Response: Thank you for pointing out this opportunity to streamline. We have changed the text to the following:

“In Zambia, Marie Stopes was active in program geographies, and at the time of baseline data collection had recently started reporting into public sector facility registers.”

Journal Requirements:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: We have reviewed the style guidelines again and made several updates to ensure that the manuscript meets PLOS One’s guidance to best of our understanding. Please inform us if there are further changes needed.

2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met. Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

Response: We have completed this questionnaire and uploaded it as requested.

3. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

Response: Thank you for your questions on consent. This work involved two types of data: from facility assessments and from aggregate routine service delivery data. Because no personal data was captured from or about individuals, both components were determined not to engage human subjects or to require consent. We have added the following text to the methods section to make this clear about each component:

Regarding facility assessments: “The IRBs determined that this work did not engage human subjects and that patient consent was not required.”

Regarding routine service delivery data: “This data is available in aggregate form without any individualized patient information, and as a result, this work was determined by CHAI’s internal Scientific and Ethical Review Committee to not engage human subjects or require patient consent.”

4. Thank you for stating in your financial disclosure: "This work was made possible with financial support from The ELMA Foundation and an anonymous donor (grants received and managed by HS and AM). The views expressed in this report are the opinions of the authors, and do not necessarily reflect the official policies of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

PLOS ONE requires you to include in your manuscript further information about the funder so that any relevant competing interests can be assessed. Please respond to the following questions:

a. Please state whether any of the research costs or authors' salaries were funded, in whole or in part, by a tobacco company (our policy on tobacco funding is at http://journals.plos.org/plosone/s/disclosure-of-funding-sources)

b. Please state whether the donor has any competing interests in relation to this work (see http://journals.plos.org/plosone/s/competing-interests) .

c. Please state whether the identity of the donor might be considered relevant to editors or reviewers’ assessment of the validity of the work.

d. If the donors have no perceived or actual competing interests, please state: “The authors are not aware of any competing interests”.

This information should be included in your cover letter. We will amend your financial disclosure and competing interests on your behalf.

Response: We confirm the following:

a. No research costs or authors' salaries were funded, in whole or in part, by a tobacco company.

b. The donor has no competing interests in relation to this work.

c. The donor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and we do not feel that the identity of the donor would be considered relevant to editors or reviewers’ assessment of the validity of the work.

d. The authors are not aware of any competing interests.

We have added this information to our cover letter for the revision, as requested. Note that another publication emerging from this same body of work and with a similar financial disclosure statement was recently published in PLOS Global Public Health:

Kamanga A, Ngosa L, Aladesanmi O, et al. Reducing maternal and neonatal mortality through integrated and sustainability-focused programming in Zambia. PLOS Glob Public Health. 2022;2(12):e0001162. Published 2022 Dec 14. doi:10.1371/journal.pgph.0001162

Please contact us if any further information is required regarding the financial disclosures.

5. Please ensure that you refer to Figures 2 to 5 in your text as, if accepted, production will need this reference to link the reader to the figure.

Response: Thank you for this point. We have included in text reference to these figures.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Response: We have updated the supplemental file references to the best of our understanding of the guidance available. Please inform us if there are further changes needed.

Attachment

Submitted filename: Response to reviewers (June 27 2023).docx

Decision Letter 1

Lea Sacca

2 Aug 2023

Strengthening systems to provide Long-Acting Reversible Contraceptives (LARCs) in public sector health facilities in Uganda and Zambia: Program results and learnings

PONE-D-23-00410R1

Dear Dr. Aldrich,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Lea Sacca

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Lea Sacca

11 Aug 2023

PONE-D-23-00410R1

Strengthening systems to provide Long-Acting Reversible Contraceptives (LARCs) in public sector health facilities in Uganda and Zambia: Program results and learnings

Dear Dr. Aldrich:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Lea Sacca

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Key LARC-related program activities.

    This table includes the LARC-related activities implemented by government and CHAI in Uganda and Zambia in this program.

    (DOCX)

    S1 File. Uganda datasets.

    (XLSX)

    S2 File. Zambia datasets.

    (XLSX)

    Attachment

    Submitted filename: Reviewer.pdf

    Attachment

    Submitted filename: Response to reviewers (June 27 2023).docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES